yondelis

May 23, 2017May 23, 2017

Yondelis Stabilized Mesothelioma in Many Patients Taking Part in Phase 2 Clinical Trial

News

Yondelis (trabectedin) stabilized a form of advanced mesothelioma that had progressed after earlier chemotherapy, according to a Phase 2 clinical trial in Italy. Researchers will present the trial’s findings at ... Read more

October 25, 2016October 26, 2016

Yondelis, Derived from Sea Cucumber, Shows Promise for Malignant Pleural Mesothelioma

News

Yondelis (trabectedin), a drug derived from the Caribbean Sea cucumber, has shown promise for treating malignant pleural mesothelioma (MPM), according to a new study published in Molecular Cancer Therapeutics, the journal of ... Read more

August 18, 2016August 18, 2016

Yondelis Combined with Chemotherapy May Be Promising Mesothelioma Therapy Approach

News

Yondelis (trabectedin), an anti-tumor drug approved for the treatment of advanced soft tissue sarcoma and ovarian cancer, has shown promising results in malignant pleural mesothelioma (MPM) cells, exerting strong anti-tumor ... Read more